HIGHLIGHTS
- who: Drahomira Holmannova and collaborators from the Institute of Preventive Medicine, Faculty of Medicine in, Charles University have published the paper: The Presence of Psoriasis, Metabolic Syndrome and Their Combination Increases the Serum Levels of CRP and CD5L but Not sCD200R1 and sTLR2 in Participants, in the Journal: (JOURNAL)
- what: The authors measured inflammatory and anti-inflammatory markers associated with psoriasis and the metabolic syndromes sTLR2, CD5L, and sCD200R1, the levels of which have not been evaluated yet.
- how: The study was conducted in accordance with the Declaration of Helsinki and the protocol . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.